Nav: Home

New studies highlight setbacks and advances in global malaria fight

April 05, 2012

Emergence of resistance to the drug artemisinin in western Thailand has created a critical point in global efforts to control and eliminate malaria worldwide, according to a new study published in the Lancet, a British Medical Journal, by researchers at the Texas Biomedical Research Institute and their collaborators in Thailand.

A second study, published concurrently in the journal Science by the same research groups, identifies a major region of the malaria parasite genome associated with artemisinin resistance, raising hope that there will soon be effective molecular markers for monitoring the spread of resistance. Both the Lancet and Science studies were funded by the National Institutes of Health and the Wellcome Trust.

Malaria killed 655,000 people - over one per minute -- in 2010. While these numbers are high, malaria deaths have declined by 30 percent over the past decade, largely because of effective control using treatment with combination therapies containing artemisinin, a plant-derived antimalarial drug developed in China.

Patients infected with malaria parasites who respond poorly to treatment have been observed in Cambodia and stimulated a coordinated World Health Organization effort to eliminate the disease in this region. That effort was based on the premise that drug-resistant malaria was confined to Cambodia. Now that effort needs to be reassessed, the Lancet study concludes.

From 2001 until 2010, the Texas Biomed team and their collaborators in Thailand studied 3,202 patients in clinics located in Northwestern Thailand, 500 miles from the Cambodian focus. They observed a dramatic decline in the drug potency over that period. Further, by measuring drug potency in patients infected with genetically identical malaria parasites, they were able to show that the decline in potency results from the spread of resistance genes.

"Spread of drug resistant malaria parasites within Southeast Asia and overspill into sub-Saharan Africa, where most malaria deaths occur, would be a public health disaster resulting in millions of deaths," said Texas Biomed's Standwell Nkhoma, Ph.D., a lead author of the Lancet report. Resistance to other antimalarial drugs, such as chloroquine and fansidar, has previously spread from Southeast Asia to Africa, providing a chilling precedent for such a scenario.

"The problem we have is that treatment with artemisinin-based drugs will promote spread of resistance, but there are no viable alternative treatment options in Southeast Asia," said Nkhoma.

"Our group wanted to understand what genetic changes have occurred in these parasites," said Texas Biomed's Ian Cheeseman, the first author of the companion report in Science "This study narrows the search to a region of the parasite genome containing around 10 genes. We haven't yet found the precise changes involved, but we are getting close."

The researchers first compared genetic variants in the genomes of parasites from Laos, which are sensitive to the drug, with parasites from Cambodia, that show high levels of resistance and those from Thailand, where both resistant and sensitive parasites occur.

"We found 33 genome regions that were very different in parasites from these three countries" said Anderson "When we examined these regions in more detail in a large collection of parasites from Thailand, we found that one small section of malaria parasite genome on chromosome 13 is strongly associated with parasite resistance".

Identification of a molecular marker for resistance will be critical for monitoring the spread of resistance, for determining how resistance occurs, and for understanding the mechanism of action of the drug. The Science study narrows the search for such a marker, and provides an important advance in the race to avert a public health crisis.
Both reports resulted from an international effort led by Texas Biomed's Tim Anderson, Ph.D., and François Nosten, M.D., at the Shoklo Malaria Research Unit in Thailand, with collaborators at Notre Dame University and in Laos and Cambodia. The other Texas Biomed authors on the reports are Shalini Nair and Salma Al-Saai.

Anderson can be reached through Joe Carey at 210-258-9437 or

Texas Biomed, formerly the Southwest Foundation for Biomedical Research, is one of the world's leading independent biomedical research institutions dedicated to advancing health worldwide through innovative biomedical research. Located on a 200-acre campus on the northwest side of San Antonio, Texas, the Institute partners with hundreds of researchers and institutions around the world to develop vaccines and therapeutics against viral pathogens causing AIDS, hepatitis, herpes, hemorrhagic fevers, and a host of other illnesses. The Institute also has programs in the genetics of cardiovascular disease, diabetes, obesity, psychiatric disorders and other diseases. For more information on Texas Biomed, go to

Texas Biomedical Research Institute

Related Parasites Articles:

Feeding bluebirds helps fend off parasites
If you feed the birds in your backyard, you may be doing more than just making sure they have a source of food: you may be helping baby birds give parasites the boot.
Scientists discover how malaria parasites import sugar
Researchers at Stockholm University has established how sugar is taken up by the malaria parasite, a discovery with the potential to improve the development of antimalarial drugs.
How malaria parasites become resistant to artemisinin antimalarial drugs
Malaria parasite mutations that inhibit the endocytoic appetite for a host's red blood cells may render them resistant to artemisinin, a widely used frontline antimalarial drug, according to a new study, which reveals a key molecular mechanism of drug resistance.
Study shows interactions between bacteria and parasites
A team at the Technical University of Munich (TUM) has completed the first study of the effects of a simultaneous infection with blood flukes (schistosomes) and the bacterium Helicobacter pylori -- a fairly common occurrence in some parts of the world.
Evolution designed by parasites
In 'Invisible Designers: Brain Evolution Through the Lens of Parasite Manipulation,' published in the September 2019 issue of The Quarterly Review of Biology, Marco Del Giudice explores an overlooked aspect of the relationship between parasites and their hosts by systematically discussing the ways in which parasitic behavior manipulation may encourage the evolution of mechanisms in the host's nervous and endocrine systems.
Airless worms: A new hope against drug-resistant parasites
Toronto scientists have uncovered a metabolic pathway that only exists in parasitic worms.
Parasites dampen beetle's fight or flight response
Beetles infected with parasitic worms put up less of a fight against simulated attacks from predators and rival males, according to a study by Felicia Ebot-Ojong, Andrew Davis and Elizabeth Jurado at the University of Georgia, USA, publishing May 22, 2019 in the open-access journal PLOS ONE.
Genome structure of malaria parasites linked to virulence
An international research team led by scientists at the University of California, Riverside, and the La Jolla Institute for Immunology has found that malaria parasite genomes are shaped by parasite-specific gene families, and that this genome organization strongly correlates with the parasite's virulence.
Parasites discovered in fossil fly pupae
Parasitic wasps existed as early as several million years ago.
Migratory animals carry more parasites, says study
Every year, billions of animals migrate across the globe, carrying parasites with them and encountering parasites through their travels.
More Parasites News and Parasites Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at